Jaguar Land Rover has shelved its plan to manufacture EVs in India at Tata Motors new Tamil Nadu plant. Tap here for more ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

EMA “The EMA has long advocated for time of use charging as it will help maximise the use of existing motorway and arterial corridors around the slowly choking ...

Jaguar Land Rover and Tata Motors end their electric vehicle joint venture in India due to economic challenges and quality ...

Tata Motors may not manufacture JLR’s EMA platform-based EVs at its upcoming 90 billion-rupee (approx. 946 million euros) ...

From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues.View on euronews ...

The Putnam County Emergency Management Agency and the Kalida Fire Department were called to the intersection of Ottawa Street ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

JLR's struggle to balance cost and quality in locally sourced components could also affect Tata's upcoming EV projects, ...

Jaguar Land Rover abandoning its EV plans for India will also put the future of Tata Motors’ Avinya range of premium EV ...

Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...